Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: risk reduction, management and possibilities for subsequent immunoregulation - PDF (Russian)
Copyright (c) 2019 Khachanova N.V., Boyko A.N., Shumilina M.V., Смагина I.V., Malkova N.A., Sivertseva S.A., Popova E.V., Khaibullin T.I.
![Creative Commons License](http://licensebuttons.net/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
![](https://kazanmedjournal.ru/files/journals/10/misc/interface/16.gif)
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-83204 от 12.05.2022.